These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9613457

  • 1. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
    Berney CR, Yang J, Fisher RJ, Russell PJ, Crowe PJ.
    Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
    [Abstract] [Full Text] [Related]

  • 2. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [Abstract] [Full Text] [Related]

  • 3. Protein markers in colorectal cancer: predictors of liver metastasis.
    Berney CR, Fisher RJ, Yang J, Russell PJ, Crowe PJ.
    Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
    [Abstract] [Full Text] [Related]

  • 4. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A.
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [Abstract] [Full Text] [Related]

  • 5. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L, Yang K.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [Abstract] [Full Text] [Related]

  • 6. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M, Lee CS.
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [Abstract] [Full Text] [Related]

  • 7. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS, Thebo JS, Senagore AJ, Duepree HJ, Gramlich T, Ormsby A, Lavery IC, Fazio VW.
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [Abstract] [Full Text] [Related]

  • 8. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
    Wei Z, Wu Y, Zhai Z.
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
    [Abstract] [Full Text] [Related]

  • 9. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
    Skelly MM, Troy A, Duffy MJ, Mulcahy HE, Duggan C, Connell TG, O'Donoghue DP, Sheahan K.
    Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
    [Abstract] [Full Text] [Related]

  • 10. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
    Tannapfel A, Katalinic A, Köckerling F, Wittekind C.
    Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
    [Abstract] [Full Text] [Related]

  • 11. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M, Cenci M, Valli C, Russo A, Bazan V, Dardanoni G, Cucciarre S, Carreca I, Macaluso MP, Tomasino RM, Vecchione A.
    Anticancer Res; 1998 Jul; 18(6A):4225-30. PubMed ID: 9891471
    [Abstract] [Full Text] [Related]

  • 12. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
    Fan YZ, Li XP, Liu WF, Li GM.
    Zhonghua Wai Ke Za Zhi; 2006 Feb 01; 44(3):181-5. PubMed ID: 16635348
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator.
    Berney CR, Yang JL, Fisher RJ, Russell PJ, Crowe PJ.
    Anticancer Res; 1998 Feb 01; 18(2A):973-7. PubMed ID: 9615749
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
    Soliani P, Ziegler S, Romani A, Corcione L, Campanini N, Dell'Abate P, Del Rio P, Sianesi M.
    Oncol Rep; 2004 Jun 01; 11(6):1193-200. PubMed ID: 15138555
    [Abstract] [Full Text] [Related]

  • 15. Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.
    Dusonchet L, Corsale S, Migliavacca M, Calò V, Bazan V, Amato A, Cammareri P, Totaro MS, Agnese V, Cascio S, La Rocca G, Sisto PS, Dardanoni G, Valerio MR, Grassi N, Latteri S, Cajozzo M, Buscemi M, Castorina S, Morello V, Tomasino RM, Gebbia N, Russo A.
    Oncol Rep; 2003 Jun 01; 10(5):1257-63. PubMed ID: 12883690
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
    Döme B, Somlai B, Tímár J.
    Anticancer Res; 2000 Jun 01; 20(5C):3971-4. PubMed ID: 11268486
    [Abstract] [Full Text] [Related]

  • 19. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.
    Royds JA, Cross SS, Silcocks PB, Scholefield JH, Rees RC, Stephenson TJ.
    J Pathol; 1994 Mar 01; 172(3):261-6. PubMed ID: 8195929
    [Abstract] [Full Text] [Related]

  • 20. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
    Lamb RF, Going JJ, Pickford I, Birnie GD.
    Cancer Res; 1996 Feb 15; 56(4):916-20. PubMed ID: 8631033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.